Study Summary
This trial is for people who have completed a Novartis trial for secukinumab, and the study is to assess the long term safety for these participants.
- Autoimmune Inflammation
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: up to 2 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Secukinumab s.c.
1 of 1
Experimental Treatment
715 Total Participants · 1 Treatment Group
Primary Treatment: Secukinumab s.c. injection · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How is Secukinumab s.c. injection typically utilized in patient care?
"Secukinumab s.c. injection is a common therapeutic option for ankylosing spondylitis and can also be utilized to treat enthesitis related arthritis (ERA), severe plaque psoriasis, and psoriatic arthritis." - Anonymous Online Contributor
Are recruitment efforts still underway for this clinical experiment?
"Affirmative. Clinicaltrials.gov hosts information which reveals that the trial, initially posted on December 22nd 2020 is in search of new participants. All told, 715 people need to be recruited from 14 distinct sites." - Anonymous Online Contributor
Has Secukinumab s.c. injection been studied in other research trials?
"Presently, there are 27 trials for Secukinumab s.c. injection in action; 13 of these investigations fall into Phase 3 testing. Despite the majority of experiments occurring in Brest and Buenos Aires, numerous test centres across 1040 locations offer this therapy to patients." - Anonymous Online Contributor
How many sites are currently facilitating this clinical experiment?
"Currently, 14 distinct sites across the United States are hosting this trial. Locations include Cumberland, Van Nuys and Denver as well as other nearby centres; it is wise to choose a site that best fits one's geographical needs in order to limit travel time." - Anonymous Online Contributor
How many individuals have enrolled in this trial to date?
"Affirmative. According to clinicaltrials.gov, this medical trial is presently enrolling patients and was first published on December 22nd 2020. The study seeks 715 individuals from 14 different sites with the most recent update being July 14th 2022." - Anonymous Online Contributor
Has Secukinumab s.c. injection been granted the green light from the FDA?
"The safety of Secukinumab s.c. injection has been verified through Phase 4 clinical trials and is given a score of 3 by the Power team's assessment scale." - Anonymous Online Contributor